Call (415) 636-9700 Phone Mon–Fri 8a–8p · Sat 9a–5p

A Pill, a Spray, and No Referee: Auvelity vs. Spravato

Ketamine therapy

A Pill, a Spray, and No Referee: Auvelity vs. Spravato

Auvelity and Spravato are both newer treatments for depression, and people often ask which is better. We searched PubMed and found no trial that compares the two head to head, so no one can say yet.

They are very different to take. Auvelity is a tablet you swallow twice a day. It combines two drugs, dextromethorphan and bupropion, and studies call it AXS-05. Spravato is a nasal spray of esketamine that you take at the clinic, where staff watch you for at least two hours afterward.

Side-by-side comparison of Auvelity, a daily tablet, and Spravato, a clinic-given nasal spray

The Auvelity trials

The first trial, called GEMINI, followed 327 adults with major depression for 6 weeks. Half took Auvelity and half took a placebo, a pill with no medicine in it (Iosifescu et al., 2022)*.

Remission, meaning the depression mostly lifted, came to 39.5% with Auvelity and 17.3% with placebo. Response, meaning symptoms dropped by at least half, came to 54% and 34%.

A second trial, called ASCEND, compared Auvelity with bupropion alone in 80 people. At week 6, 46.5% on Auvelity were in remission, versus 16.2% on bupropion (Tabuteau et al., 2022)*.

Common side effects were dizziness, nausea, headache, sleepiness and dry mouth.

The Spravato trials

We cover the Spravato studies in another article. That drug was tested in people whose depression had not lifted with other medicines.

Why the numbers do not line up

The trials used different people, different lengths and different measures, so a figure from one cannot sit next to a figure from another. The two Auvelity trials also enrolled adults with major depression, not specifically treatment-resistant depression.

Choosing between them

The right fit depends on your history, your other medicines, and how much time and travel each option asks of you. Auvelity changes how your body clears some other medicines, so your clinician needs your full medication list.

A licensed clinician can walk through both options with you.

Exxceed Wellness offers evaluations in Hayward and by telehealth across California. If you are thinking about harming yourself, call or text 988 right away.

Keep reading

Educational information only, not medical advice. If you are in crisis, call or text 988.

Sources

  1. Iosifescu, D. V., et al. (2022). Efficacy and safety of AXS-05 (dextromethorphan-bupropion) in patients with major depressive disorder: a phase 3 randomized clinical trial (GEMINI). Journal of Clinical Psychiatry, 83(4). https://doi.org/10.4088/JCP.21m14345
  2. Tabuteau, H., et al. (2022). Effect of AXS-05 (dextromethorphan-bupropion) in major depressive disorder: a randomized double-blind controlled trial. American Journal of Psychiatry, 179(7), 490-499. https://doi.org/10.1176/appi.ajp.21080800

*Most authors of these studies work for Axsome Therapeutics, the company that makes Auvelity.

Leave A Comment

Your email address will not be published. Required fields are marked *

Serving the East Bay: Hayward, CA  ·  Castro Valley, CA  ·  San Lorenzo, CA  ·  San Leandro, CA  ·  Union City, CA  ·  Newark, CA  ·  Fremont, CA